Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Mar;83(3):311–316. doi: 10.1136/bjo.83.3.311

"Cyclodiode": results of a standard protocol

A F Spencer 1, S Vernon 1
PMCID: PMC1722956  PMID: 10365039

Abstract

AIMS—To analyse the results of intraocular pressure (IOP) reduction in refractory glaucoma following diode laser cyclophotocoagulation with a repeatable standard protocol.
METHODS—58 eyes of 53 patients were followed for 6-37 months (mean 19 months) after initial cyclodiode treatment.
RESULTS—Mean (SD) pretreatment IOP for the 58 eyes was 33.0 mm Hg (10.7) reducing at final index visit to 16.7 mm Hg (7.8) (p<0.0001). The mean antiglaucoma medication score per eye was significantly reduced from 2.4 (0.8) to 1.4 (1.0) at last index visit (p<0.0001) with 91% of patients able to stop oral acetazolamide. 45% of eyes required more than one treatment and the overall mean per eye was 1.6 (range 1-5). Of eyes with visual acuity 6/60 or better pretreatment, 12 (32%) lost more than two lines of Snellen acuity and two eyes with poorer acuity initially dropped to NPL. Poor visual outcome was associated with the presence of diabetic retinopathy. Hypotony (IOP <5 mm Hg) was noted in two eyes at the last index visit although neither had specific signs of the same. No phthisis was seen.
CONCLUSION—The simple treatment protocol, repeated if necessary, appears relatively safe and effective at lowering IOP in eyes with refractory glaucoma.

 Keywords: diode laser; cyclophotocoagulation; refractory glaucoma

Full Text

The Full Text of this article is available as a PDF (119.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

Pretreatment IOP is plotted against IOP at last index visit (mm Hg). The oblique line is the line of equivalence. The horizontal broken line is at 22 mm Hg.

Figure 2  .

Figure 2  

Open in a new tab

Visual acuity pretreatment compared with final follow up. The solid line represents no change in acuity, the broken lines above and below represent a change of two Snellen lines or grades of acuity. The number next to each point is the number of eyes at each point.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assia E. I., Hennis H. L., Stewart W. C., Legler U. F., Carlson A. N., Apple D. J. A comparison of neodymium: yttrium aluminum garnet and diode laser transscleral cyclophotocoagulation and cyclocryotherapy. Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2774–2778. [PubMed] [Google Scholar]
  2. BIETTI G. Surgical intervention on the ciliary body; new trends for the relief of glaucoma. J Am Med Assoc. 1950 Mar 25;142(12):889–897. doi: 10.1001/jama.1950.02910300027006. [DOI] [PubMed] [Google Scholar]
  3. Beckman H., Kinoshita A., Rota A. N., Sugar H. S. Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1972 Mar-Apr;76(2):423–436. [PubMed] [Google Scholar]
  4. Beckman H., Sugar H. S. Neodymium laser cyclocoagulation. Arch Ophthalmol. 1973 Jul;90(1):27–28. doi: 10.1001/archopht.1973.01000050029006. [DOI] [PubMed] [Google Scholar]
  5. Benson M. T., Nelson M. E. Cyclocryotherapy: a review of cases over a 10-year period. Br J Ophthalmol. 1990 Feb;74(2):103–105. doi: 10.1136/bjo.74.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bloom P. A., Tsai J. C., Sharma K., Miller M. H., Rice N. S., Hitchings R. A., Khaw P. T. "Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology. 1997 Sep;104(9):1508–1520. doi: 10.1016/s0161-6420(97)30109-2. [DOI] [PubMed] [Google Scholar]
  7. Bock C. J., Freedman S. F., Buckley E. G., Shields M. B. Transscleral diode laser cyclophotocoagulation for refractory pediatric glaucomas. J Pediatr Ophthalmol Strabismus. 1997 Jul-Aug;34(4):235–239. doi: 10.3928/0191-3913-19970701-11. [DOI] [PubMed] [Google Scholar]
  8. Brancato R., Carassa R. G., Bettin P., Fiori M., Trabucchi G. Contact transscleral cyclophotocoagulation with diode laser in refractory glaucoma. Eur J Ophthalmol. 1995 Jan-Mar;5(1):32–39. doi: 10.1177/112067219500500106. [DOI] [PubMed] [Google Scholar]
  9. Brancato R., Leoni G., Trabucchi G., Cappellini A. Histopathology of continuous wave neodymium: yttrium aluminum garnet and diode laser contact transscleral lesions in rabbit ciliary body. A comparative study. Invest Ophthalmol Vis Sci. 1991 Apr;32(5):1586–1592. [PubMed] [Google Scholar]
  10. Dickens C. J., Nguyen N., Mora J. S., Iwach A. G., Gaffney M. M., Wong P. C., Tran H. Long-term results of noncontact transscleral neodymium:YAG cyclophotocoagulation. Ophthalmology. 1995 Dec;102(12):1777–1781. doi: 10.1016/s0161-6420(95)30794-4. [DOI] [PubMed] [Google Scholar]
  11. Fankhauser F., van der Zypen E., Kwasniewska S., Rol P., England C. Transscleral cyclophotocoagulation using a neodymium YAG laser. Ophthalmic Surg. 1986 Feb;17(2):94–100. [PubMed] [Google Scholar]
  12. Finger P. T., Smith P. D., Paglione R. W., Perry H. D. Transscleral microwave cyclodestruction. Invest Ophthalmol Vis Sci. 1990 Oct;31(10):2151–2155. [PubMed] [Google Scholar]
  13. Gaasterland D. E., Pollack I. P. Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma. Trans Am Ophthalmol Soc. 1992;90:225–246. [PMC free article] [PubMed] [Google Scholar]
  14. Hampton C., Shields M. B., Miller K. N., Blasini M. Evaluation of a protocol for transscleral neodymium: YAG cyclophotocoagulation in one hundred patients. Ophthalmology. 1990 Jul;97(7):910–917. doi: 10.1016/s0161-6420(90)32482-x. [DOI] [PubMed] [Google Scholar]
  15. Hawkins T. A., Stewart W. C. One-year results of semiconductor transscleral cyclophotocoagulation in patients with glaucoma. Arch Ophthalmol. 1993 Apr;111(4):488–491. doi: 10.1001/archopht.1993.01090040080035. [DOI] [PubMed] [Google Scholar]
  16. Hennis H. L., Stewart W. C. Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma. Am J Ophthalmol. 1992 Jan 15;113(1):81–85. doi: 10.1016/s0002-9394(14)75758-7. [DOI] [PubMed] [Google Scholar]
  17. Kosoko O., Gaasterland D. E., Pollack I. P., Enger C. L. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology. 1996 Aug;103(8):1294–1302. doi: 10.1016/s0161-6420(96)30508-3. [DOI] [PubMed] [Google Scholar]
  18. Lee P. F. Argon laser photocoagulation of the ciliary processes in cases of aphakic glaucoma. Arch Ophthalmol. 1979 Nov;97(11):2135–2138. doi: 10.1001/archopht.1979.01020020453008. [DOI] [PubMed] [Google Scholar]
  19. Noureddin B. N., Wilson-Holt N., Lavin M., Jeffrey M., Hitchings R. A. Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery. Ophthalmology. 1992 Mar;99(3):430–437. [PubMed] [Google Scholar]
  20. Schuman J. S., Bellows A. R., Shingleton B. J., Latina M. A., Allingham R. R., Belcher C. D., Puliafito C. A. Contact transscleral Nd:YAG laser cyclophotocoagulation. Midterm results. Ophthalmology. 1992 Jul;99(7):1089–1095. doi: 10.1016/s0161-6420(92)31846-9. [DOI] [PubMed] [Google Scholar]
  21. WEEKERS R., LAVERGNE G., WATILLON M., GILSON M., LEGROS A. M. Effects of photocoagulation of ciliary body upon ocular tension. Am J Ophthalmol. 1961 Aug;52:156–163. doi: 10.1016/0002-9394(61)91110-2. [DOI] [PubMed] [Google Scholar]
  22. al-Ghamdi S., al-Obeidan S., Tomey K. F., al-Jadaan I. Transscleral neodymium:YAG laser cyclophotocoagulation for end-stage glaucoma, refractory glaucoma, and painful blind eyes. Ophthalmic Surg. 1993 Aug;24(8):526–529. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES